Iron overload contributes to general anaesthesia-induced neurotoxicity and cognitive deficits
Jing Wu, Jianjun Yang, Yan Cao, Huihui Li, Hongting Zhao, Shuofei Yang, Kuanyu Li
Journal of Neuroinflammation April 10, 2020 DOI: 10.1186/s12974-020-01777-6 via OpenAlex
Summary
AI-generated from the abstractGeneral anesthesia induced by ketamine or sevoflurane disrupts iron metabolism, causing iron overload in hippocampal neurons and brain tissue. This iron overload triggers ferroptosis, a form of iron-dependent cell death, leading to cognitive deficits in young rats and aged mice. The iron chelator deferiprone reduces mitochondrial dysfunction, ferroptosis, and cognitive impairment. The mechanism involves NMDAR-RASD1 signaling activating DMT1, which mediates iron uptake. Disturbed iron metabolism may contribute to anesthesia-related neurotoxicity and cognitive decline.
Study at a glance
| Characteristics | Experimental study with in vitro and in vivo models Peer reviewed |
|---|---|
| Population | Primary hippocampal neurons, young rats, and aged mice |
| Interventions | ketamine sevoflurane deferiprone |
| Topics | Ketamine |
| Keywords | Neurotoxicity Hippocampal formation Neurodegeneration Hippocampus Neuroscience |
| Citations | 140 |
| Key finding | General anesthesia causes iron overload via NMDAR-RASD1 signaling and DMT1, leading to ferroptosis and cognitive deficits, which are attenuated by iron chelation. |
Abstract
Abstract Background Increasing evidence suggests that multiple or long-time exposure to general anaesthesia (GA) could be detrimental to cognitive development in young subjects and might also contribute to accelerated neurodegeneration in the elderly. Iron is essential for normal neuronal function, and excess iron in the brain is implicated in several neurodegenerative diseases. However, the role of iron in GA-induced neurotoxicity and cognitive deficits remains elusive. Methods We used the primary hippocampal neurons and rodents including young rats and aged mice to examine whether GA impacted iron metabolism and whether the impact contributed to neuronal outcomes. In addition, a pharmacological suppression of iron metabolism was performed to explore the molecular mechanism underlying GA-mediated iron overload in the brain. Results Our results demonstrated that GA, induced by intravenous ketamine or inhalational sevoflurane, disturbed iron homeostasis and caused iron overload in both in vitro hippocampal neuron culture and in vivo hippocampus. Interestingly, ketamine- or sevoflurane-induced cognitive deficits, very likely, resulted from a novel iron-dependent regulated cell death, ferroptosis. Notably, iron chelator deferiprone attenuated the GA-induced mitochondrial dysfunction, ferroptosis, and further cognitive deficits. Moreover, we found that GA-induced iron overload was activated by NMDAR-RASD1 signalling via DMT1 action in the brain. Conclusion We conclude that disturbed iron metabolism may be involved in the pathogenesis of GA-induced neurotoxicity and cognitive deficits. Our study provides new vision for consideration in GA-associated neurological disorders.